Figure legends
Figure 1. Correlation analysis of the ILC2 prevalence in sinonasal tissues and in preoperative (pre-op) blood. Correlations between the ILC2 prevalence in sinonasal tissues and that in pre-op blood (A), the ILC2 prevalence in sinonasal tissues and the pre-op Lund-Mackay CT (LMK-CT) score (B), the ILC2 prevalence in pre-op blood and the pre-op LMK-CT score (C), the ILC2 prevalence in sinonasal tissues and the postoperative (post-op) LMK-CT score (D), and the ILC2 prevalence in pre-op blood and the post-op LMK-CT score (E). eCRS, eosinophilic chronic rhinosinusitis.
Figure 2. Correlation analysis of the ILC2 prevalence in sinonasal tissues and in pre-op blood with the post-op outcomes in the eCRS and non-eCRS patients. Correlations between the ILC2 prevalence in sinonasal tissues and the post-op LMK-CT score improvement rate (A), and the ILC2 prevalence in pre-op blood and the post-op LMK-CT score improvement rate (B).
Figure 3. Changes in the ILC2 prevalence in blood (A) and in the LMK-CT score (B) before and after ESS.
Figure 4. Changes in the ILC2 prevalence in blood before and after ESS in the good outcome group (A) and the poor outcome group (B).